Unlock instant, AI-driven research and patent intelligence for your innovation.

Crystal form of cytarabine 5'-o-l-valine ester hydrochloride and preparation method thereof

A technology of cytarabine and valine ester, which is applied in the crystal form of cytarabine 5′-O-L-valine ester hydrochloride and its preparation field, and can solve the problem of low yield and poor chemical stability Good, difficult to obtain new crystal forms and other problems, to achieve the effect of high purity, crystal form stability and high chemical stability

Active Publication Date: 2021-04-09
KUNMING JIDA PHARMA
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the chemical stability of the crystal form I of the above-mentioned cytarabine 5'-O-L-valine ester hydrochloride is poor, and the yield in the preparation process is low, so it is not suitable for industrial production
[0006] After a lot of research, it was found that cytarabine 5′-O-L-valine ester hydrochloride is easy to obtain the above crystal form I, but it is difficult to obtain the new crystal form

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Crystal form of cytarabine 5'-o-l-valine ester hydrochloride and preparation method thereof
  • Crystal form of cytarabine 5'-o-l-valine ester hydrochloride and preparation method thereof
  • Crystal form of cytarabine 5'-o-l-valine ester hydrochloride and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0044] Equipment used and operating conditions

[0045] X-ray powder diffraction instrument: D8-Advance X-ray diffractometer (measurement conditions: radiation source: copper target; 2θ scanning range 3°~60°; step length 0.02° / step; residence time 0.1 second / step; tube pressure = 40KV; pipe flow = 100mA, etc.)

[0046] Infrared spectrophotometer: NICOLET-5700 Fourier Transform Infrared Spectrometer of American Thermoelectric Company (measurement conditions: sample preparation by potassium bromide tablet method; test range: 400cm -1 ~4000cm -1 . )

Synthetic example

[0048] According to the preparation method of cytarabine 5′-O-L-valine ester hydrochloride reported in the patent document CN105273023A, the details are as follows:

[0049] 1) Using commercially available cytarabine as the starting material and absolute ethanol as the solvent, add N,N-dimethylformamide dimethyl acetal (DMF-DMA), heat up to 65°C, and stir for 4 hours , after the reaction, the reaction solution was cooled to room temperature, filtered, the solid was washed with methyl tert-butyl ether, and dried under vacuum at 45°C to obtain intermediate 1;

[0050] 2) Add intermediate 1 into DMF and stir to dissolve, add Boc-L-valine potassium, stir at room temperature for 1 hour, cool down to -10°C ~ -5°C, add ethyl chloroformate dropwise, after the dropwise, heat up React at 0°C for 4 hours, then rise to room temperature for 2 hours, add isopropyl ether, stir and crystallize at 0°C for 2 hours, filter, dissolve the filter cake in chloroform, wash with 15% sodium carbonate s...

Embodiment 1

[0057] Add 20 g of cytarabine 5′-O-L-valine ester hydrochloride crystal form I obtained by the above synthesis example into 400 ml of DMF, stir at room temperature for 14 days, filter, and then air-dry at 60°C to obtain 19.2 g Solid, yield 96%, purity 99.5%.

[0058] Adopt above-mentioned X-ray powder diffraction instrument and infrared spectrophotometer to analyze gained solid respectively under above-mentioned measuring condition, its X-ray powder diffraction collection of patterns and IR collection of illustrative plates are respectively as follows figure 1 , 2 As shown, it was determined to be the crystal form II of cytarabine 5'-O-L-valine ester hydrochloride.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a crystal form of cytarabine 5'-O-L-valine ester hydrochloride and a preparation method thereof. The crystalline form II of cytarabine 5′-O-L-valine ester hydrochloride of the present invention uses Cu-Kα radiation, and the powder X-ray diffraction spectrum represented by the 2θ angle is at 7.4±0.2°, 8.8±0.2 °, 14.6±0.2°, 19.8±0.2°, 22.1±0.2°, 23.2±0.2° and 25.1±0.2° have diffraction peaks. The crystal form II of cytarabine 5′-O-L-valine ester hydrochloride of the present invention has the advantages of stable physical and chemical properties, high yield, and suitability for industrial production.

Description

technical field [0001] The invention relates to the technical field of crystal compounds, in particular to a crystal form of cytarabine 5'-O-L-valine ester hydrochloride and a preparation method thereof. Background technique [0002] Cytarabine is converted into active cytarabine triphosphate in the body, which prevents DNA synthesis and inhibits cell growth. Clinically, cytarabine is mainly used to treat acute myeloid leukemia. However, cytarabine has a large molecular polarity and poor membrane permeability, resulting in low oral bioavailability. [0003] In the patent document CN101812105A, the research group of Professor He Zhonggui of Shenyang Pharmaceutical University modified the structure of cytarabine and synthesized a series of pharmaceutically acceptable salts of 5′-O-amino acid esters of cytarabine for the first time. These compounds significantly improved The membrane permeability of cytarabine was improved, especially, the absolute bioavailability of cytarabin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07H19/09C07H1/06A61P35/02A61K31/7068
CPCA61P35/02C07B2200/13C07H1/06C07H19/09
Inventor 王春水张朴永金寅张云
Owner KUNMING JIDA PHARMA